Search
On August 18, 2025, HuiMei Technology, a pioneering medical AI solution provider, announced the successful conclusion of a new funding round amounting to nearly 200 million yuan. This significant capital injection was spearheaded by Shanghai Science and Innovation Fund and Zhongding Capital, with Qiming Venture Capital continuing its support and Changning Capital joining forces through the Hongqiao Ruizhi Investment Platform. HuiMei Technology is dedicated to addressing critical clinical challenges leveraging AI technology, with its comprehensive AI product suite now serving over 1,200 hospitals of varying levels, among which over 70% are tertiary institutions. This latest round of funding will undoubtedly propel the company's technological advancements and accelerate its market penetration.
-
C114 Communication Network -
Communication Home
